Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Decision

Decision

Prioritisation programme

Prioritisation programme

Showing 51 to 75 of 389

TitlePrioritisation programmeDecisionDecision date
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]None selectedNot selected
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]None selectedNot selected
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]None selectedNot selected
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]None selectedNot selected
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]None selectedNot selected
Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165]None selectedNot selected
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]None selectedNot selected
Epicranial focal cortex stimulation for drug-resistant focal epilepsyNone selectedNot selected
Percutaneous nephrolithotomy for kidney stones greater than 1.5cmNone selectedNot selected
Mosunetuzumab for treating relapsed or refractory follicular lymphoma [TSID 12081]None selectedNot selected
Subcutaneous nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over [TSID 12178]None selectedNot selected
Nifedipine - Lidocaine for Chronic Anal Fissure [TSID 12093]None selectedNot selected
Diltiazem (Anatop, SLV-324, VEN 307) for Anal fissure [TSID 12100]None selectedNot selected
Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166]None selectedAwaiting decision
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106None selectedNot selected
Orforglipron for treating type 2 diabetes [TSID12130]None selectedNot selected
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]None selectedNot selected
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]None selectedNot selected
AHEAD implants for external ear prosthesisNone selectedNot selected
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]None selectedNot selected
Infrared lasers for treating onychomycosisNone selectedFurther information required
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]None selectedNot selected
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]None selectedNot selected
Doravirine-islatravir for previously untreated HIV-1 infection [TSID12172]None selectedNot selected
Intradiscal oxygen-ozone treatment of symptomatic lumbar disc herniationNone selectedAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All